NovoCure

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NovoCure and other ETFs, options, and stocks.

About NVCR

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division.

CEO

Ashley Cordova

CEOAshley Cordova

Employees

1,488

Employees1,488

Headquarters

St. Helier, Jersey

HeadquartersSt. Helier, Jersey

Founded

2000

Founded2000

Employees

1,488

Employees1,488

NVCR Key Statistics

Market cap

1.43B

Market cap1.43B

Price-Earnings ratio

-8.21

Price-Earnings ratio-8.21

Dividend yield

—

Dividend yield—

Average volume

1.28M

Average volume1.28M

High today

$13.48

High today$13.48

Low today

$12.47

Low today$12.47

Open price

$12.78

Open price$12.78

Volume

1.84M

Volume1.84M

52 Week high

$34.13

52 Week high$34.13

52 Week low

$10.87

52 Week low$10.87

NVCR News

TipRanks 3d

Novocure reports Q3 EPS (33c), consensus (42c)

Reports Q3 revenue $167.2M, consensus $158.94M. “Q3 was a solid quarter with steady commercial execution in glioblastoma, geographic expansion, and material pro...

Analyst ratings

63%

of 8 ratings

Buy

62.5%

Hold

37.5%

Sell

People also own

Based on the portfolios of people who own NVCR. This list is generated using Robinhood data, and it’s not a recommendation.